Literature DB >> 12738890

Low vitamin B6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification.

Peter J Kelly1, Vivian E Shih, J Philip Kistler, Megan Barron, Hang Lee, Roseann Mandell, Karen L Furie.   

Abstract

BACKGROUND AND
PURPOSE: The introduction of cereal grain folic acid fortification in 1998 has reduced homocyst(e)ine (tHcy) concentrations in the US population. We performed a case-control study to determine the risk of stroke and transient ischemic attack (TIA) associated with tHcy and low vitamin status in a postfortification US sample.
METHODS: Consecutive cases with new ischemic stroke/TIA were compared with matched controls. Fasting tHcy, folate, pyridoxal 5'-phosphate (PLP), B12, and MTHFR 677C-->T genotype were measured.
RESULTS: Mean PLP was significantly lower in cases than controls (39.97 versus 84.1 nmol/L, P<0.0001). After stroke risk factors were controlled for, a strong independent association was present between stroke/TIA and low PLP (adjusted odds ratio [OR], 4.6; 95% CI, 1.4 to 15.1; P<0.001) but not elevated tHcy (OR, 0.92; 95% CI, 0.4 to 2.1).
CONCLUSIONS: Low B6 but not tHcy was strongly associated with cerebrovascular disease in this postfortification, folate-replete sample.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738890     DOI: 10.1161/01.STR.0000071109.23410.AB

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Principal-component analysis for assessment of population stratification in mitochondrial medical genetics.

Authors:  Alessandro Biffi; Christopher D Anderson; Michael A Nalls; Rosanna Rahman; Akshata Sonni; Lynelle Cortellini; Natalia S Rost; Mar Matarin; Dena G Hernandez; Anna Plourde; Paul I W de Bakker; Owen A Ross; Steven M Greenberg; Karen L Furie; James F Meschia; Andrew B Singleton; Richa Saxena; Jonathan Rosand
Journal:  Am J Hum Genet       Date:  2010-05-27       Impact factor: 11.025

Review 2.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

3.  Metabolite profile analysis reveals association of vitamin B-6 with metabolites related to one-carbon metabolism and tryptophan catabolism but not with biomarkers of inflammation in oral contraceptive users and reveals the effects of oral contraceptives on these processes.

Authors:  Luisa Rios-Avila; Bonnie Coats; Yueh-Yun Chi; Øivind Midttun; Per M Ueland; Peter W Stacpoole; Jesse F Gregory
Journal:  J Nutr       Date:  2014-11-19       Impact factor: 4.798

4.  Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults.

Authors:  Lydia Sakakeeny; Ronenn Roubenoff; Martin Obin; Joao D Fontes; Emelia J Benjamin; Yoram Bujanover; Paul F Jacques; Jacob Selhub
Journal:  J Nutr       Date:  2012-05-23       Impact factor: 4.798

5.  Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat.

Authors:  Nicholas J Kuypers; Michael R Hoane
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

6.  Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status.

Authors:  Martha Savaria Morris; Lydia Sakakeeny; Paul F Jacques; Mary Frances Picciano; Jacob Selhub
Journal:  J Nutr       Date:  2009-11-11       Impact factor: 4.798

7.  Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women.

Authors:  Yvonne Lamers; Bruce O'Rourke; Lesa R Gilbert; Christine Keeling; Dwight E Matthews; Peter W Stacpoole; Jesse F Gregory
Journal:  Am J Clin Nutr       Date:  2009-06-10       Impact factor: 7.045

Review 8.  Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.

Authors:  Elisabetta Trabetti
Journal:  J Appl Genet       Date:  2008       Impact factor: 3.240

9.  Prevention of mutation, cancer, and other age-associated diseases by optimizing micronutrient intake.

Authors:  Bruce N Ames
Journal:  J Nucleic Acids       Date:  2010-09-22

Review 10.  Homocysteine and cognitive function in elderly people.

Authors:  Angeles Garcia; Katherine Zanibbi
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.